Coherus Biosciences (CHRS) Earnings (2013 - 2026)
Coherus Biosciences (CHRS) earnings from Sep 30, 2013 to Mar 31, 2026. The TTM Coherus Biosciences (CHRS) earnings is $186M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Annual Earnings change of Coherus Biosciences (CHRS)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$38M | -122.81% |
| 2025 | $168M | +489.34% |
| 2024 | $29M | -111.98% |
| 2023 | -$238M | -18.46% |
| 2022 | -$292M | +1.62% |
| 2021 | -$287M | -317.11% |
| 2020 | $132M | +47.21% |
| 2019 | $90M | -142.91% |
| 2018 | -$209M | -12.10% |
| 2017 | -$238M | +87.03% |
| 2016 | -$127M | -42.96% |
| 2015 | -$223M | +156.24% |
| 2014 | -$87M | +62.47% |
| 2013 | -$54M | +62.42% |
| 2012 | -$33M | N/A |